| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/19/2007 | WO2006110882A3 Hmgcoa reductase inhibitor codrugs and uses thereof |
| 07/19/2007 | WO2006037623A3 New nuclear transcription factors regulators |
| 07/19/2007 | WO2005120546A3 Compositions and methods for topical diagnostic and therapeutic transport |
| 07/19/2007 | WO2005089805A3 Polymer-based compositions and conjugates of hiv entry inhibitors |
| 07/19/2007 | US20070167644 Bifunctional energy-reversible acyl-compositions |
| 07/19/2007 | US20070167610 Recombinant soluble adenovirus receptor |
| 07/19/2007 | US20070167512 Lipid metabolism improving agent |
| 07/19/2007 | US20070167401 novel cyclodextrin derivatives, polysubstituted but also monosubstituted, in primary alcohol position by reacting halogenated cyclodextrin with aminoalkanethiol or the salt of aminoalklanethio to form intermediate, then with an isothiocyanate containing biorecognition element such as amino acid, peptide |
| 07/19/2007 | US20070167393 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/19/2007 | US20070167368 Dried blood factor composition comprising trehalose |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070167364 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/19/2007 | US20070167352 preparing an oxygenated hemoglobin solution; thiolating with 2-iminothiolane to form thiolated oxygenated hemoglobin;reacting intermediate with maleimidyl polyethylene glycol to form polyethylene glycol modified hemoglobin; autooxidation resistance; superior oxygen transporter |
| 07/19/2007 | US20070167351 Peptide/Lipid Complex Formation by Co-Lyphilization |
| 07/19/2007 | US20070166385 Method of inhibiting restenosis using bisphosphonates |
| 07/19/2007 | US20070166383 Anionic hydrogel matrices with ph dependent modified release as drug carriers |
| 07/19/2007 | US20070166382 Bioresponsive polymer system for delivery of microbicides |
| 07/19/2007 | US20070166377 Water solubility; silicones; vaccines |
| 07/19/2007 | US20070166376 Solid pharmaceutical preparation |
| 07/19/2007 | US20070166374 Orally administering edible oil homogenized with an edible wax and stigmasterol, campesterol, beta -sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and/or poriferasterol; repairing and promoting regeneration of mucosa in gastrointestinal tract |
| 07/19/2007 | US20070166368 Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents |
| 07/19/2007 | US20070166367 Adept or gdept producing acetaldehyde |
| 07/19/2007 | US20070166360 External preparation |
| 07/19/2007 | US20070166355 Food and feed supplement and its use |
| 07/19/2007 | US20070166354 Method of reducing the risk of retinopathy of prematurity in preterm infants |
| 07/19/2007 | US20070166317 Microparticles |
| 07/19/2007 | US20070166315 Vibrio cholerae o139 conjugate vaccines |
| 07/19/2007 | US20070166296 Therapeutic Systems |
| 07/19/2007 | US20070166278 Novel g-csf conjugates |
| 07/19/2007 | US20070166277 Polymeric reagents comprising a ketone or a related functional group |
| 07/19/2007 | US20070166276 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 07/19/2007 | US20070166268 Thickener compositions comprising sclerotium gum and a copolymer |
| 07/19/2007 | US20070166249 Pharmaceutical and cosmetic formulations for treating fingernails |
| 07/19/2007 | DE4131276B4 Peroral applizierbare Metoclopramidlösungen Orally administered Metoclopramidlösungen |
| 07/19/2007 | DE102006002793A1 Liquid pharmaceutical form comprises electrically charged solution having electrical diffusion characteristic, and other usual active substances, where the pharmaceutical form is introduced into blood stream of patient without syringe |
| 07/19/2007 | CA2636838A1 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
| 07/19/2007 | CA2635724A1 Thermoreversible oil-in-water emulsion |
| 07/19/2007 | CA2632962A1 Sustained release preparation and method for production thereof |
| 07/18/2007 | EP1808438A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/18/2007 | EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 07/18/2007 | EP1808183A2 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/18/2007 | EP1808181A1 Polysaccharide-cyclodextrin conjugates |
| 07/18/2007 | EP1808174A1 Medicament compositions based on tiotropium salts and on salmeterol salts |
| 07/18/2007 | EP1808161A1 Microprojectile delivery system and particulate product |
| 07/18/2007 | EP1808160A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/18/2007 | EP1808155A2 Antibody-serum protein hybrids |
| 07/18/2007 | EP1807146A2 Composition for improving efficiency of drug delivery |
| 07/18/2007 | EP1807115A1 Nanoparticles comprising an intracellular targeting element and preparation and use thereof |
| 07/18/2007 | EP1807114A2 Bioadhesive composition with programmed release |
| 07/18/2007 | EP1807113A2 Sustained release of active molecules from polymers topically applied to skin or hair |
| 07/18/2007 | EP1807112A1 Stable aqueous formulation of a platin derivative |
| 07/18/2007 | EP1807068A1 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption |
| 07/18/2007 | EP1807053A1 Liposomal formulation of bortezomib (ps-341) |
| 07/18/2007 | EP1807052A1 Liposome formulation of peptide boronic acids compounds |
| 07/18/2007 | EP1807047A2 Sodium ascorbate solubilisate |
| 07/18/2007 | EP1807018A2 In situ controlled release drug delivery system |
| 07/18/2007 | EP1652836B1 Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents |
| 07/18/2007 | EP1503722B1 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 07/18/2007 | EP1497436B1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 07/18/2007 | EP1383482B1 Method for manufacturing a low dose pharmaceutical composition |
| 07/18/2007 | EP1377280B1 Use of bulking agents as satiety agents |
| 07/18/2007 | EP1180097B1 Mutual salt of amlodipine and atorvastatin |
| 07/18/2007 | EP1178780B1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 07/18/2007 | EP1143938B1 Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids |
| 07/18/2007 | EP0859751B2 Semi-fluorinated alkanes and their use |
| 07/18/2007 | EP0840623B1 Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles |
| 07/18/2007 | EP0770140B1 Composition containing nucleic acids and cationic polymers, preparation and uses |
| 07/18/2007 | CN1326882C Carcino-embryonic untigen specific combined peptide and fusion protein with TNF-alpha |
| 07/18/2007 | CN1326877C Specific antibody fragments for the human carcinoembryonic antigen (CEA) |
| 07/18/2007 | CN1326569C Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/18/2007 | CN1326528C Process for preparing arsenic magnetized nanometer glutin minipill |
| 07/18/2007 | CN1326524C Stable liquid preparation |
| 07/18/2007 | CN1326517C Process for preparing dry extracts |
| 07/18/2007 | CN1326467C Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes |
| 07/18/2007 | CN101001858A S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
| 07/18/2007 | CN101001646A Stabilized synthetic immunogen delivery system |
| 07/18/2007 | CN101001639A Pegylation of vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase activating peptide (PACAP) receptor 2 (VPAC2) agonists and methods of use |
| 07/18/2007 | CN101001629A Medicinal composition |
| 07/18/2007 | CN101001622A Capsule stable against mastication |
| 07/18/2007 | CN101001618A Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 07/18/2007 | CN101001614A Ion binding polymers and uses thereof |
| 07/18/2007 | CN101001609A Method of manufacturing pharmaceutical preparations containing liposomes |
| 07/18/2007 | CN100999752A Antioxydizing peptide mixture from collagen and its preparation process and use |
| 07/18/2007 | CN100999546A Polypeptide compound with aza-containing heterocyclic modified and its application |
| 07/18/2007 | CN100999510A Preparation of noncrystal form ede plene oxalate and its coprecipitate |
| 07/18/2007 | CN100999508A Process of extracting algal brown pigment from brown alga and use thereof |
| 07/18/2007 | CN100999496A Compound of polyphenols with aza-containing heterocyclic modified and use thereof |
| 07/18/2007 | CN100999495A Compound of styryl with axa-containing heterocyclic modified and use thereof |
| 07/18/2007 | CN100998872A Polypeptide medicine intercalation hydrotalcite and its preparation method |
| 07/18/2007 | CN100998871A Chiral medicine D-antothenic acid intercalation hydrotalcite and its preparation method |
| 07/18/2007 | CN100998870A Stable polymer micelle medicine carrging system |
| 07/18/2007 | CN100998869A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998868A Antientity tumour composition |
| 07/18/2007 | CN100998867A Anticancer Chinese medicine compound nanometer emulsion and its preparation method |
| 07/18/2007 | CN100998864A Cyclosporin A semisolid skeleton capsule and its preparation method |
| 07/18/2007 | CN100998862A Ossotide glucose injection |
| 07/18/2007 | CN100998853A Chinese medicine for treating articular disease and its preparation method |
| 07/18/2007 | CN100998835A Preparation for treating angiocardiopathy and its preparation method |